HBA-NRS H.C.R. 8 77(R) BILL ANALYSIS Office of House Bill AnalysisH.C.R. 8 By: Marchant Public Health 3/28/2001 Introduced BACKGROUND AND PURPOSE Muscular dystrophy is a disease that encompasses a large group of hereditary muscle-destroying disorders, with Duchenne muscular dystrophy being the most common disorder and the most fatal childhood genetic disease. Continuing research on muscular dystrophy is important to understanding the disease, treating it, and working towards its prevention and cure. Congressional funding for research by the National Institutes of Health on Duchenne and Becker muscular dystrophy does not reflect the severity of this disease, the importance of finding a cure, or the potential benefits that research in this area could have on other similar disorders. House Concurrent Resolution 8 urges the United States Congress to increase funding for the research of Duchenne and Becker muscular dystrophy. RULEMAKING AUTHORITY It is the opinion of the Office of House Bill Analysis that this bill does not expressly delegate any additional rulemaking authority to a state officer, department, agency, or institution. ANALYSIS House Concurrent Resolution 8 urges the Congress of the United States to increase funding for research by the National Institutes of Health for the treatment and cure of Duchenne and Becker muscular dystrophy.